CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $254,000,000 | -25.9% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $343,000,000 | -18.5% | 20,000 | -39.6% | 0.01% | -33.3% |
| Q3 2015 | $421,000,000 | -9.3% | 33,112 | 0.0% | 0.01% | +12.5% |
| Q2 2015 | $464,000,000 | – | 33,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |